Estudio multicéntrico, prospectivo, de comparación del tratamiento de la tromboembolia pulmonar submasiva con enoxaparina y heparina no fraccionadaMulticenter, prospective study comparing enoxaparin with unfractionated heparin in the treatment of submassive pulmonary thromboembolism
Bibliografía (16)
- et al.
Incidence of acute pulmonary embolism in a general hospital: relation to age, sex, and race
Chest
(1999) - et al.
The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: outcome of therapy and health economy aspects. low-molecular-weight heparin versus unfractionated heparin
Haemostasis
(1998) - et al.
Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A metaanalysis of randomized, controlled trials
Ann Intern Med
(1999) - et al.
Randomized trial of subcutaneous low-molecular- weight heparin CY 216 (fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism. A dose-ranging study
Circulation
(1992) - et al.
Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study
Thromb Haemost
(1995) Low-molecular-weight heparin in the treatment of patients with venous thromboembolism
N Engl J Med
(1997)- et al.
A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group
Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med
(1997) - et al.
Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group
Arch Intern Med
(2000)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2003 Sociedad Española de Neumología y Cirugía Torácica. Published by Elsevier España, S.L. All rights reserved.